These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 16717465)

  • 21. Predictors of infarct size after primary coronary angioplasty in acute myocardial infarction from pooled analysis from four contemporary trials.
    Stone GW; Dixon SR; Grines CL; Cox DA; Webb JG; Brodie BR; Griffin JJ; Martin JL; Fahy M; Mehran R; Miller TD; Gibbons RJ; O'Neill WW
    Am J Cardiol; 2007 Nov; 100(9):1370-5. PubMed ID: 17950792
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Myocardial salvage after coronary stenting plus abciximab versus fibrinolysis plus abciximab in patients with acute myocardial infarction: a randomised trial.
    Kastrati A; Mehilli J; Dirschinger J; Schricke U; Neverve J; Pache J; Martinoff S; Neumann FJ; Nekolla S; Blasini R; Seyfarth M; Schwaiger M; Schömig A;
    Lancet; 2002 Mar; 359(9310):920-5. PubMed ID: 11918909
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Facilitated percutaneous coronary intervention (PCI) in patients with acute ST-elevation myocardial infarction: comparison of prehospital tirofiban versus fibrinolysis before direct PCI.
    Möckel M; Bocksch W; Strohm S; Kühnle Y; Vollert J; Nibbe L; Dietz R
    Int J Cardiol; 2005 Aug; 103(2):193-200. PubMed ID: 16080980
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Early resolution of ST-segment elevation correlates with myocardial salvage assessed by Tc-99m sestamibi scintigraphy in patients with acute myocardial infarction after mechanical or thrombolytic reperfusion therapy.
    Dong J; Ndrepepa G; Schmitt C; Mehilli J; Schmieder S; Schwaiger M; Schömig A; Kastrati A
    Circulation; 2002 Jun; 105(25):2946-9. PubMed ID: 12081985
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison in patients having primary coronary angioplasty of abciximab versus tirofiban on recovery of left ventricular function.
    Danzi GB; Sesana M; Capuano C; Mauri L; Berra Centurini P; Baglini R
    Am J Cardiol; 2004 Jul; 94(1):35-9. PubMed ID: 15219505
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Therapy-dependent influence of time-to-treatment interval on myocardial salvage in patients with acute myocardial infarction treated with coronary artery stenting or thrombolysis.
    Schömig A; Ndrepepa G; Mehilli J; Schwaiger M; Schühlen H; Nekolla S; Pache J; Martinoff S; Bollwein H; Kastrati A
    Circulation; 2003 Sep; 108(9):1084-8. PubMed ID: 12925458
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Safety and efficacy of thrombolysis with alteplase (50 mg) plus tirofiban versus alteplase (100 mg) alone in acute myocardial infarction: preliminary findings.
    Sarullo FM; Pasquale PD; D'Alfonso G; Amerigo L; Cannizzaro S; Castello A
    Ital Heart J; 2001 Aug; 2(8):605-11. PubMed ID: 11577835
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Beneficial effects of intracoronary tirofiban bolus administration following upstream intravenous treatment in patients with ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention: the ICT-AMI study.
    Zhu TQ; Zhang Q; Qiu JP; Jin HG; Lu L; Shen J; Zhao LP; Zhang RY; Hu J; Yang ZK; Shen WF
    Int J Cardiol; 2013 May; 165(3):437-43. PubMed ID: 21940058
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparison of angioplasty with infusion of tirofiban or abciximab and with implantation of sirolimus-eluting or uncoated stents for acute myocardial infarction: the MULTISTRATEGY randomized trial.
    Valgimigli M; Campo G; Percoco G; Bolognese L; Vassanelli C; Colangelo S; de Cesare N; Rodriguez AE; Ferrario M; Moreno R; Piva T; Sheiban I; Pasquetto G; Prati F; Nazzaro MS; Parrinello G; Ferrari R;
    JAMA; 2008 Apr; 299(15):1788-99. PubMed ID: 18375998
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prognostic value of myocardial salvage achieved by reperfusion therapy in patients with acute myocardial infarction.
    Ndrepepa G; Mehilli J; Schwaiger M; Schühlen H; Nekolla S; Martinoff S; Schmitt C; Dirschinger J; Schömig A; Kastrati A
    J Nucl Med; 2004 May; 45(5):725-9. PubMed ID: 15136618
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Periprocedural use of tirofiban in elective percutaneous coronary intervention for long coronary lesions in stable patients with overlapping drug-eluting stents--the PETITION study: a prospective, randomized, multicenter study.
    Zhang Q; Wang XL; Liao ML; Hu J; Yang ZK; Ding FH; Zhang JS; Du R; Zhu TQ; Shen WF; Zhang RY
    Catheter Cardiovasc Interv; 2015 Mar; 85 Suppl 1():762-9. PubMed ID: 25630513
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Routine early versus deferred provisional tirofiban treatment in patients with acute coronary syndrome undergoing percutaneous coronary intervention.
    Zhang Y; Gao C; Liu H; Wang X; Yang H; Li M; Wang X; Zhu Z; Hu D
    Clin Exp Pharmacol Physiol; 2013 Apr; 40(4):289-94. PubMed ID: 23551127
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Primary angioplasty vs. early routine post-fibrinolysis angioplasty for acute myocardial infarction with ST-segment elevation: the GRACIA-2 non-inferiority, randomized, controlled trial.
    Fernández-Avilés F; Alonso JJ; Peña G; Blanco J; Alonso-Briales J; López-Mesa J; Fernández-Vázquez F; Moreu J; Hernández RA; Castro-Beiras A; Gabriel R; Gibson CM; Sánchez PL;
    Eur Heart J; 2007 Apr; 28(8):949-60. PubMed ID: 17244641
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A randomized, double-blinded, placebo-controlled, dose-ranging study measuring the effect of an adenosine agonist on infarct size reduction in patients undergoing primary percutaneous transluminal coronary angioplasty: the ADMIRE (AmP579 Delivery for Myocardial Infarction REduction) study.
    Kopecky SL; Aviles RJ; Bell MR; Lobl JK; Tipping D; Frommell G; Ramsey K; Holland AE; Midei M; Jain A; Kellett M; Gibbons RJ;
    Am Heart J; 2003 Jul; 146(1):146-52. PubMed ID: 12851624
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Safety and efficacy of early administration of tirofiban in patients with acute ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention: a meta-analysis.
    Liu Y; Su Q; Li L
    Chin Med J (Engl); 2014; 127(6):1126-32. PubMed ID: 24622446
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Changes in BNP, hs-CRP and TIMI risk index with addition of tirofiban during primary percutaneous coronary intervention for acute STEMI: a prospective observational cohort study.
    Kurt IH; Demirkol S; Ünal I; Batur MK
    Anadolu Kardiyol Derg; 2012 Mar; 12(2):107-14. PubMed ID: 22281789
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Increase of myocardial salvage and left ventricular function recovery with intracoronary abciximab downstream of the coronary occlusion in patients with acute myocardial infarction treated with primary coronary intervention.
    Bellandi F; Maioli M; Gallopin M; Toso A; Dabizzi RP
    Catheter Cardiovasc Interv; 2004 Jun; 62(2):186-92. PubMed ID: 15170708
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Randomized comparison of intracoronary tirofiban versus urokinase as an adjunct to primary percutaneous coronary intervention in patients with acute ST-elevation myocardial infarction: results of the ICTUS-AMI trial.
    Zhu TQ; Zhang Q; Ding FH; Qiu JP; Jin HG; Jiang L; Lu L; Zhang RY; Hu J; Yang ZK; Shen Y; Shen WF
    Chin Med J (Engl); 2013 Aug; 126(16):3079-86. PubMed ID: 23981616
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Impact of selective infarct-related artery infusion of tirofiban on myocardial reperfusion and bleeding complications in patients with acute myocardial infarction: the SUIT-AMI trial.
    Chen Y; Zhou P; Yan H; Zhao H; Song L; Liu C; Zhao B; Chi Y; Wang S; Wang J
    J Invasive Cardiol; 2013 Aug; 25(8):376-82. PubMed ID: 23913601
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Transfer with GP IIb/IIIa inhibitor tirofiban for primary percutaneous coronary intervention vs. on-site thrombolysis in patients with ST-elevation myocardial infarction (STEMI): a randomized open-label study for patients admitted to community hospitals.
    Dobrzycki S; Kralisz P; Nowak K; Prokopczuk P; Kochman W; Korecki J; Poniatowski B; Zuk J; Sitniewska E; Bachorzewska-Gajewska H; Sienkiewicz J; Musial WJ
    Eur Heart J; 2007 Oct; 28(20):2438-48. PubMed ID: 17884846
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.